The Cambridge biotech is working on new ways to discover and develop “agonist antibodies,” and its Series A round was co-led by Atlas Venture and BVF Partners.
Source link
Atlas-backed Diagonal Therapeutics launches with $128M
![](https://fuerza943.com/wp-content/uploads/2024/04/unknown100xx801-801-200-0.jpg)
The Cambridge biotech is working on new ways to discover and develop “agonist antibodies,” and its Series A round was co-led by Atlas Venture and BVF Partners.
Source link